Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Vella LA"'
Autor:
Gilang Ramadhan, Annisa Krisridwany, Andy Eko Wibowo, Muhammad Fariez Kurniawan, Vella Lailli Damarwati
Publikováno v:
Jurnal Farmasi Sains dan Praktis, Vol 9, Iss 2 (2023)
Infectious disease is a major health problem with a relatively high mortality rate. Indonesia is rich in natural ingredients that have potential as antibacterials, one of which is the Karamunting plant (Rhodomyrtus tomentosa). Several studies on this
Externí odkaz:
https://doaj.org/article/0819a7db44e4428e997de283c35d8c96
Publikováno v:
JPSCR: Journal of Pharmaceutical Science and Clinical Research, Vol 5, Iss 2, Pp 179-188 (2020)
Jamu merupakan obat tradisional yang banyak digunakan masyarakat untuk mencegah atau membantu menyembuhkan berbagai penyakit. Peningkatan minat masyarakat untuk mengkonsumsi jamu sering disalahgunakan oleh produsen dengan menambahkan Bahan Kimia Obat
Externí odkaz:
https://doaj.org/article/85b743669a354f0b95399dc5a3e56062
Publikováno v:
Pharmaciana, Vol 10, Iss 1, Pp 35-42 (2020)
Empirically, arrowroot tubers (Maranta arundinacea L.) have been widely used in the treatment of gastric ulcers. They are known to contain carbohydrates and flavonoids that play a role in reducing inflammation. This study sought to identify the gastr
Externí odkaz:
https://doaj.org/article/0b278e3aab064e60bc5f481fa7b0b909
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masters Colin L, Li Qiao-Xin, Caragounis Aphrodite, Liddell Jeffrey R, Price Katherine A, Ng Dominic CH, Vella Laura J, Parker Sarah J, Meyerowitz Jodi, Nonaka Takashi, Hasegawa Masato, Bogoyevitch Marie A, Kanninen Katja M, Crouch Peter J, White Anthony R
Publikováno v:
Molecular Neurodegeneration, Vol 6, Iss 1, p 57 (2011)
Abstract Background TDP-43 proteinopathies are characterized by loss of nuclear TDP-43 expression and formation of C-terminal TDP-43 fragmentation and accumulation in the cytoplasm. Recent studies have shown that TDP-43 can accumulate in RNA stress g
Externí odkaz:
https://doaj.org/article/7eb8bb9338a94b95ba64d05ebbf17b5f
Autor:
Chong EA; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Kumashie KG; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia., Chong ER; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania., Fabrizio J; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania., Gupta A; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Svoboda J; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Barta SK; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Walsh KM; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania., Napier EB; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania., Lundberg RK; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania., Nasta SD; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Gerson JN; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Landsburg DJ; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Gonzalez J; Immune Health., Gaano A; Immune Health., Weirick ME; Department of Microbiology., McAllister CM; Department of Microbiology., Awofolaju M; Department of Microbiology., John GN; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia., Kammerman SC; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia., Novacek J; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia., Pajarillo R; Center for Cellular Immunotherapies., Lundgreen KA; Department of Microbiology., Tanenbaum N; Department of Microbiology., Gouma S; Department of Microbiology., Drapeau EM; Department of Microbiology., Adamski S; Institute for Immunology.; Department of Pathology and Laboratory Medicine., D'Andrea K; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Pattekar A; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine., Hicks A; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Korte S; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Sharma H; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Herring S; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Williams JC; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Hamilton JT; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Bates P; Department of Microbiology., Hensley SE; Department of Microbiology., Prak ETL; Immune Health.; Department of Pathology and Laboratory Medicine., Greenplate AR; Institute for Immunology.; Department of Pathology and Laboratory Medicine., Wherry EJ; Institute for Immunology.; Department of Pathology and Laboratory Medicine.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Schuster SJ; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania., Ruella M; The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.; Division of Hematology/Oncology, Hospital of the University of Pennsylvania.; Center for Cellular Immunotherapies.; Institute for Immunology., Vella LA; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia.; Department of Pathology and Laboratory Medicine.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jul 25; Vol. 230 (1), pp. 15-27.
Autor:
Guruprasad P; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Carturan A; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Zhang Y; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Cho JH; Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA., Kumashie KG; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Patel RP; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Kim KH; R&D Center, AbClon Inc., Seoul, Republic of Korea., Lee JS; R&D Center, AbClon Inc., Seoul, Republic of Korea., Lee Y; R&D Center, AbClon Inc., Seoul, Republic of Korea., Kim JH; R&D Center, AbClon Inc., Seoul, Republic of Korea., Chung J; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Joshi A; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Cohen I; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Shestov M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ghilardi G; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Harris J; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Pajarillo R; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Angelos M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Lee YG; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea., Liu S; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA., Rodriguez J; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Wang M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ballard HJ; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Gupta A; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ugwuanyi OH; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Hong SJA; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Bochi-Layec AC; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Sauter CT; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Chen L; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Paruzzo L; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Kammerman S; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Shestova O; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Liu D; Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA., Vella LA; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Schuster SJ; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Svoboda J; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Porazzi P; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ruella M; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Jun; Vol. 25 (6), pp. 1020-1032. Date of Electronic Publication: 2024 Jun 03.
Autor:
Thomson Z; Allen Institute for Immunology, Seattle, WA, USA., He Z; Allen Institute for Immunology, Seattle, WA, USA., Swanson E; Allen Institute for Immunology, Seattle, WA, USA.; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA., Henderson K; Allen Institute for Immunology, Seattle, WA, USA., Phalen C; Allen Institute for Immunology, Seattle, WA, USA., Zaim SR; Allen Institute for Immunology, Seattle, WA, USA., Pebworth MP; Allen Institute for Immunology, Seattle, WA, USA., Okada LY; Allen Institute for Immunology, Seattle, WA, USA., Heubeck AT; Allen Institute for Immunology, Seattle, WA, USA., Roll CR; Allen Institute for Immunology, Seattle, WA, USA.; Microbiology, Immunology and Cancer Biology (MICaB) Program, University of Minnesota, Minneapolis, Minneapolis, MN, USA., Hernandez V; Allen Institute for Immunology, Seattle, WA, USA., Weiss M; Allen Institute for Immunology, Seattle, WA, USA., Genge PC; Allen Institute for Immunology, Seattle, WA, USA., Reading J; Allen Institute for Immunology, Seattle, WA, USA., Giles JR; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Manne S; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Dougherty J; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Jasen CJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Greenplate AR; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.; Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Becker LA; Allen Institute for Immunology, Seattle, WA, USA., Graybuck LT; Allen Institute for Immunology, Seattle, WA, USA., Vasaikar SV; Allen Institute for Immunology, Seattle, WA, USA.; Seagen, Bothell, WA, USA., Szeto GL; Allen Institute for Immunology, Seattle, WA, USA.; Seagen, Bothell, WA, USA., Savage AK; Allen Institute for Immunology, Seattle, WA, USA., Speake C; Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Buckner JH; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Li XJ; Allen Institute for Immunology, Seattle, WA, USA., Bumol TF; Allen Institute for Immunology, Seattle, WA, USA., Wherry EJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Torgerson TR; Allen Institute for Immunology, Seattle, WA, USA., Vella LA; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pediatrics, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Henrickson SE; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pediatrics, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Skene PJ; Allen Institute for Immunology, Seattle, WA, USA. peter.skene@alleninstitute.org., Gustafson CE; Allen Institute for Immunology, Seattle, WA, USA. claire.gustafson@alleninstitute.org.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Mar; Vol. 25 (3), pp. 577.
Autor:
Vella LA, Berna AZ, Blatz AM, Logan J, Sharma P, Liu Y, Tedesco J, Toland C, Babiker L, Hafertepe K, Kammerman S, Novacek J, Akaho E, Gonzalez AK, Taylor D, Diorio C, Balamuth F, Bassiri H, Odom John AR
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jan 15. Date of Electronic Publication: 2024 Jan 15.